Top Categories
Products
Add Listing
Tegoprubart | Novus Therapeutics, Inc.
Product description
Tegoprubart is an anti-CD40L antibody in clinical development for the prevention of organ transplant rejection. It is being evaluated in Phase 2 and Phase 1b clinical trials.
Novus Therapeutics, Inc.
Irvine, United States (US)
Price:
N/A
Quote request
Message
